JAN 19, 2015 12:00 AM PST

Axonal Transport Study Provides New Hope for MS Patients

In order to survive and power the human brain for its millions of functions, neurons in the cerebral cortex need a steady supply of food. This food comes in the form of regular amounts of proteins and organelles. There is one route for this supply to the brain and that is the axon. Axons are the transport avenue for the entire nervous system but the delivery of proteins and organelles to the brain is perhaps the most precious cargo.

Axonal transport is the process that gets this cargo to the brain and recent studies show that the disruption of this process is a key factor in many neurodegenerative diseases. Within in the axon there are tiny spindle-like microtubules that run the length of the axon. These pathways are essentially the train tracks used by motor proteins bring the necessary food supply to the neurons in the brain.

In a study published in the December issue of the journal Neuron, researchers demonstrated that axonal transport is disrupted in mice with experimental autoimmune encephalomyelitis (EAE), which is an animal model of the disease Multiple Sclerosis (MS). Researchers were also able to demonstrate that this disruption, while pervasive, was reversible.

Using two-photon microscopy researchers were able to see directly into every layer of the living tissues of the lab animals. They noted that the transport of mitochondria, the food supply for neurons, was significantly slower and paused more often in the EAE mice, even when the axons in the affected mice appeared normal. The team suggested that the disruption was likely due to both the inflammatory process and the demyelination process of EAE, and it's human counterpart, MS.

The study also showed that the transport problems occurred before any signs of abnormalities in the microtubules could be seen. Researchers also noted a difference between the mice with chronic EAE and the acute form. In mice with the acute form, the axonal transport problems sometimes resolved spontaneously and in those that didn't were reversed with anti-inflammatory application or redox scavenging.

The disruption of the axonal transport persisted in the mice with chronic EAE, suggesting that in humans with progressive MS, this disruption could be responsible for the rapid degeneration of nerve tissue and the accompanying decline of muscle function. Researchers stressed that early detection of transport difficulties could prevent the disease from slipping into the devastating degenerative phase and believe that this study will shed light on new approaches to treating the progressive form of MS.
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
SEP 21, 2020
Cannabis Sciences
Why Do We Build Tolerance to Cannabis?
SEP 21, 2020
Why Do We Build Tolerance to Cannabis?
Many notice that after regularly smoking cannabis, it takes more and more to feel its effects- if any at all. While abst ...
OCT 12, 2020
Cannabis Sciences
Can Cannabis Relieve Symptoms of Down Syndrome?
OCT 12, 2020
Can Cannabis Relieve Symptoms of Down Syndrome?
Increasing anecdotal and academic evidence has been emerging in recent years about the plethora of health benefits behin ...
OCT 07, 2020
Neuroscience
Biocompatible Gel Restores Sciatic Nerve Function in Rats
OCT 07, 2020
Biocompatible Gel Restores Sciatic Nerve Function in Rats
Video: Explains poly(lactic-co-glycolic acid), a hydrogel biopolymer that is a similar concept to the new hydrogel built ...
NOV 08, 2020
Cannabis Sciences
Can Cannabis Treat Epilepsy?
NOV 08, 2020
Can Cannabis Treat Epilepsy?
There has been growing interest in recent years for cannabis to treat central nervous system disorders. And so far, ther ...
NOV 20, 2020
Drug Discovery & Development
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
NOV 20, 2020
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
Researchers from the UK and France have discussed a mechanism of action behind the infamous Toxoplasma gondii  ...
NOV 29, 2020
Genetics & Genomics
Gene Therapy for Eye Disorder May Have Other Applications
NOV 29, 2020
Gene Therapy for Eye Disorder May Have Other Applications
In recent years, scientists have been able to develop gene therapies to treat some eye diseases. The eyes are uniquely q ...
Loading Comments...